Patents by Inventor Todd F. Ovokaitys

Todd F. Ovokaitys has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8404733
    Abstract: The invention provides a blend of amino acid powders that have been exposed to pulsed laser radiation. The pulsed laser radiation is obtained by passing laser radiation through a device, which has a first diffraction grating, a second diffraction grating, and a refractive element positioned between the first and second diffraction gratings. Passing the laser radiation through the device cancels a portion of the laser radiation by destructive interference, and produces pulses of laser radiation by constructive interference. The blend of laser treated amino acids has been found useful in regenerating active myocardial tissue. The invention further provides a process for preparing the laser treated blend of amino acid powders and a method of regenerating active myocardial tissue with the blend.
    Type: Grant
    Filed: February 14, 2011
    Date of Patent: March 26, 2013
    Inventors: Todd F. Ovokaitys, Vladimir S. Fedorov
  • Patent number: 8377989
    Abstract: The present invention provides stable non-crystalline aspirin that does not crystallize at room temperature during storage for prolonged periods of time and processes for obtaining the stable non-crystalline aspirin.
    Type: Grant
    Filed: October 16, 2008
    Date of Patent: February 19, 2013
    Inventors: Todd F. Ovokaitys, John Scott Strachan
  • Publication number: 20120220641
    Abstract: The invention provides a blend of amino acid powders that have been exposed to pulsed laser radiation. The pulsed laser radiation is obtained by passing laser radiation through a device, which has a first diffraction grating, a second diffraction grating, and a refractive element positioned between the first and second diffraction gratings. Passing the laser radiation through the device cancels a portion of the laser radiation by destructive interference, and produces pulses of laser radiation by constructive interference. The blend of laser treated amino acids has been found useful in regenerating active myocardial tissue. The invention further provides a process for preparing the laser treated blend of amino acid powders and a method of regenerating active myocardial tissue with the blend.
    Type: Application
    Filed: February 14, 2011
    Publication date: August 30, 2012
    Inventors: Todd F. OVOKAITYS, V. S. FEDOROV
  • Patent number: 8173632
    Abstract: The invention provides a process for preparing non-crystalline organic compositions and non-crystalline, co-amorphous blends of organic compounds.
    Type: Grant
    Filed: October 16, 2008
    Date of Patent: May 8, 2012
    Inventors: Todd F. Ovokaitys, John Scott Strachan
  • Publication number: 20090131376
    Abstract: The invention provides a process for preparing non-crystalline organic compositions and non-crystalline, co-amorphous blends of organic compounds.
    Type: Application
    Filed: October 16, 2008
    Publication date: May 21, 2009
    Inventors: Todd F. Ovokaitys, John Scott Strachan
  • Publication number: 20090131710
    Abstract: The present invention provides stable non-crystalline aspirin that does not crystallize at room temperature during storage for prolonged periods of time and processes for obtaining the stable non-crystalline aspirin.
    Type: Application
    Filed: October 16, 2008
    Publication date: May 21, 2009
    Inventors: Todd F. Ovokaitys, John Scott Strachan
  • Publication number: 20040230257
    Abstract: A method for improving the bioavailability of a bioactive substance includes subjecting the bioactive substance to laser radiation. The laser radiation modifies the bioactive substance to thereby modify reactions relating thereto in the body. The method enables reductions in inflammation associated with autoimmune diseases, modification of reaction by-products in the body, increased homogenization and flattening of molecular shape and improved methylation. The improved methylation can be utilized to reduce homocysteine blood levels, and to reduce anxiety, depression, paranoia, hostility, somatization (perception of bodily distress) and obsessive-compulsive symptoms. Enhanced nitric oxide generation from modified L-arginine can be used to reduce systolic and diastolic blood pressure, lower total and LDL cholesterol levels, and improve the ratio of total to HDL cholesterol.
    Type: Application
    Filed: February 9, 2004
    Publication date: November 18, 2004
    Inventor: Todd F. Ovokaitys
  • Publication number: 20040204746
    Abstract: A method for improving the bioavailability of a bioactive substance includes subjecting the bioactive substance to laser radiation. The laser radiation modifies the bioactive substance to thereby modify reactions relating thereto in the body. The method enables reductions in inflammation associated with autoimmune diseases, modification of reaction by-products in the body, increased homogenization and flattening of molecular shape and improved methylation. The improved methylation can be utilized to reduce homocysteine blood levels, and to reduce anxiety, depression, paranoia, hostility, somatization (perception of bodily distress) and obsessive-compulsive symptoms. Enhanced nitric oxide generation from modified L-arginine can be used to reduce systolic and diastolic blood pressure, lower total and LDL cholesterol levels, and improve the ratio of total to HDL cholesterol.
    Type: Application
    Filed: February 9, 2004
    Publication date: October 14, 2004
    Inventors: Todd F. Ovokaitys, John Scott Strachan